Indian benchmark indices traded higher on Wednesday, September 22, supported by declining crude oil prices and easing concerns over elevated energy costs. According to reports from LiveMint, the Nifty 50 advanced 0.5% to 23,446.80, while the BSE Sensex gained 0.4% to 74,828.25. The indices were up 0.44% and 0.36% respectively ahead of the closing auction. The decline in oil prices provided relief to India, which relies heavily on crude imports, with Brent crude remaining below the $100-a-barrel mark.
Market sentiment received support from developments around the US-Iran conflict, as reported by LiveMint. US President Donald Trump warned of further military action against Iran while indicating that discussions involving Iranian mediators had been productive. After showing weakness near the 23,500 hurdle on Tuesday, Nifty 50 bounced back firmly on Wednesday with a long bull candle formation on the daily chart that has almost surpassed the bearish candle of Tuesday. According to Nagaraj Shetti, Senior Technical Research Analyst of HDFC Securities, a decisive breakout above 23,600 could open renewed buying in the market, with any dips to support at 23,250 viewed as buying opportunities.
IKS Health (IKS Healthcare Solutions Limited) is recommended as a buy at ₹1,928 with a target of ₹2,080 and stop loss at ₹1,845 for a timeframe of 2-3 weeks, as reported by LiveMint. After showing range-bound action in recent months, the healthcare technology stock witnessed a decisive breakout this week. The stock price is currently positioned at the edge of surpassing crucial hurdle levels around ₹1,950-1,960. PB Fintech is recommended as a buy at ₹1,893 with a target of ₹2,045 and stop loss at ₹1,815 for the same 2-3 week timeframe. The fintech stock bounced back sharply on Wednesday after witnessing moderate downward correction in the last two weeks.
According to LiveMint, with crude prices remaining a key market driver, investors are closely tracking developments in the Middle East. A sustained moderation in oil prices could ease pressure on India's import bill and inflation outlook, while any fresh escalation in the conflict could quickly reverse recent relief. The mixed signals from US-Iran developments kept investors cautious about the possibility of further escalation, limiting the market's gains despite positive oil price movements.
